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HRMAS NMR is considered a valuable technique to obtain detailed metabolic profile of unprocessed tissues. To properly interpret
the HRMAS metabolomic results, detailed information of the actual state of the sample inside the rotor is needed. MRM (Magnetic
Resonance Microscopy) was applied for obtaining structural and spatially localized metabolic information of the samples inside
the HRMAS rotors. The tissue was observed stuck to the rotor wall under the eﬀect of HRMAS spinning. MRM spectroscopy
showed a transference of metabolites from the tissue to the medium. The sample shape and the metabolite transfer after HRMAS
indicated that tissue had undergone alterations and it can not be strictly considered as intact. This must be considered when
HRMAS is used for metabolic tissue characterization, and it is expected to be highly dependent on the manipulation of the sample.
The localized spectroscopic information of MRM reveals the biochemical compartmentalization on tissue samples hidden in the
HRMAS spectrum.
1. Introduction
NMR is a very valuable tool for the study of healthy
or diseased brain given the possible translation of that
knowledge to the clinical practice. Brain tumors are among
the most studied pathologies by NMR in its diﬀerent
modalities. In vivo NMR spectroscopy (MRS) can support
tumor presurgical diagnosis (tumor identification, border
delineation and infiltration detection) as well as treatment
monitoring [1–5]. In in vivo MRS the spatial and spectral
resolution are limited. With the purpose to obtain a better
metabolite identification and quantification, high-resolution
NMR has been applied to the tumor tissue ex vivo. These
studies were initially performed in solution, and required a
previous chemical extraction with Perchloric acid or organic
solvents [6, 7]. High-Resolution Magic Angle Spinning
(HRMAS) NMR has become in recent years a valuable
technique to obtain detailed metabolic profiles of brain
tumors [8–13]. This technique requires low tissue amount
(ca. 20 mg) and minimum sample handling compared to
chemical extracts. Probably because this limited processing
of the sample [9–11], HRMAS is considered a metabolomic
technique that provides “intact” tissue spectra. Nevertheless,
some researchers have shown some reluctance to assume
the integrity of the tissue due to the sample handling
and measurement conditions. An issue of interest is the
postmortem interval for tissue obtained from autopsies,
or in the case of pieces from resection, the time that the
sample remains in the surgery room before being preserved.
The results so far obtained show that this time period
between tissue death and tissue preservation causes changes
in the tissue metabolite concentration [8, 14] as might
be expected. Knowing this eﬀect, the temperature to run
the experiments needs to be low to preserve as much as
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possible the biochemical profile. In fact, comparing the
biochemical profiles of experiments at 20◦C and 2◦C, there
were 4-fold reduction in the content of some metabolites
at 20◦C compared to 2◦C [8], which indicates the tissue
degradation at 20◦C. However, it has also been found that for
tissue maintained at 4◦C and spinning at 5 kHz there were
more significant changes in the metabolite concentrations
over 4 hours of measurement than the changes due to the
delayed initial freezing [14]. The cellular damage by high
spinning speed of HRMAS seems to be promoting some
release of metabolites that previously were NMR-invisible
[14]. Finally, the eﬀect of freezing-thawing the tissue samples
has been of interest for some researchers [15, 16]. Freezing
and thawing of any tissue is likely to cause unpredictable
amounts of cell damage and lysis [16]. In some tissues there
have been reported changes in the molecular composition
of the samples frozen, compared to samples studied without
previous freezing. According to these researchers, tissue
samples that are subjected to freezing will undergo some
physical disruption of cellular compartmentalization and
changes in molecular composition [15]. Moreover, the
tissues thawed after freezing show that a great amount of
metabolites (40%–50% for human prostate and 20% for rat
brain) leak into the storage buﬀer at the time that thawing is
completed, and the amount of a given metabolite observed
in the medium varies from one biopsy to another and is not
proportional to the amount originally present in the tissue
[16].
Therefore, a proper biochemical interpretation of the
HRMAS results would require detailed and localized molec-
ular information on the tissue that can be correlated
with the histopathological analysis and other molecular
characterization techniques. It would be advisable as well
to know the actual state of the tissue inside the rotor
and a direct visualization could be of help, providing, as
additional information, the overall shape of the sample. This
study shows the potential role of NMR microscopy, MRM
(Magnetic Resonance Microscopy), in obtaining structural
and spatially localized metabolic information of the tissue
samples inside the HRMAS rotors and to study the real
integrity of the tissue in HRMAS. With this objective MRM
imaging, MRM spectroscopy, and HRMAS has been applied
to the study of human Glioblastoma Multiforme (GBM)
biopsies.
Gliomas are the most common primary brain tumors.
GBM is the highest glioma grade and the most common
malignant central nervous system tumor in adults [17, 18].
2. Materials andMethods
This study was reviewed and approved by the ethics commit-
tee of the Hospital de la Ribera, Alzira, Spain. Informed con-
sent was obtained from all patients as a part of eTUMOUR
Project (FP6-2002-LSH 503094). Eight GBM samples (A–
H) were studied by MRM and HRMAS inside 4 mm/50 µL
ZrO2 rotors. Sample preparation was done following already
published procedures [9]. The amount of tumoral tissue
ranged from 9.8 to 27.3 mg (see Table 1). This quantity was
split from the whole tumoral mass submerged in liquid
nitrogen. Samples were introduced in the rotor without
flushing, thus avoiding the leakage of metabolites reported
in the washing of tissues [16]. The volume of the rotor was
fitted with cool D2O. Then, the rotor was transferred into
the NMR probe precooled to 6◦C. In both probes, MRM and
HRMAS, the real temperature was internally assessed using a
100% MeOH sample in a 4 mm rotor in the same conditions
than the samples.
Several settings were tested: MRM and HRMAS exper-
iments were performed on two tissue samples extracted
from the same tumor (samples A–E), MRM before HRMAS
(sample F), and MRM after HRMAS (samples G and H).
Moreover, in sample G the solution part was separated
from the tissue at the end of the HRMAS and MRM
studies and introduced in a 4 mm/12 µL rotor to acquire
an additional HRMAS CPMG spectrum. Details of the
experiments performed on each sample are given in Table 1.
MRM studies were conducted in a 14 T magnet (Bruker
Avance DRX 600 spectrometer operating at a 1H frequency
of 600.13 MHz) connected to a microimage console with
a gradient system of 300 G/cm at 60 A current (Bruker
Biospin). The instrument was equipped with a standard bore
Micro 5 imaging probehead with an rf insert of 5 mm. A
Bruker Cooling Unit Extreme controlled the temperature
during the acquisition. HRMAS experiments were conducted
in an 11.7 T magnet (Bruker Avance DRX 500 spectrometer
operating at a 1H frequency of 500.13 MHz). The instrument
was equipped with a 4 mm triple resonance 1H/31P/13C
HRMAS probe. A Bruker cooling unit was used to control the
temperature by cooling down the bearing air flowing into the
probe. Sample temperature was 6◦C for MRM and HRMAS
experiments.
In the MRM study of each sample, a global shimming
was performed first, including the whole content of the rotor.
The tissue pieces were then localized inside the rotors using
imaging multislice sequences RARE (Rapid Acquisition
with Relaxation Enhancement) with TR/TE 2000/80 ms and
MDEFT (Modified Driven-Equilibrium Fourier Transform)
with TR/TE 5000/4.5 ms adapted to MRM. In these RARE
and MDEFT images, the FOV was 10 mm and the slice
thickness was 500 µm. The matrix dimensions were 256 ×
256 elements, which gave an in-plane spatial resolution of 39
× 39 µm. MRM-localized spectroscopy was performed with
PRESS (Point resolved spectroscopy) single voxel (TR/TE
2100/12 ms). Before acquiring each single voxel spectrum,
a specific shimming was performed, shimming only the
volume determined by each single voxel and optimizing
the 1st-order shims. This shimming procedure was repeated
in each location, tissue and solution, for each sample.
VAPOR (Variable pulse power and optimized relaxation
delays) was used for water suppression. The spectral width
was 10 ppm/6000 Hz and the number of points was 4k.
Depending on the volume selected, the number of repetitions
was from 512 to 4096. Single-voxel PRESS spectroscopy was
performed in the tissue, and the solution parts in samples A–
G. Single-voxel in sample H was acquired only in the solution
part, since the tissue piece was a thin slice stuck to the rotor
wall.
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Table 1: MRM and HRMAS experiments for each tumor and sample.
GBM tumor
Sample
ID
Weight (mg)
MRM
Weight (mg)
HRMAS
Medium
MRM single-voxel
dimensions (mm)
HRMAS performance
1 A 20.6 21.5 1 × 1 × 1
2 B 16.7 17.3 D2O 1 × 1 × 1 Parallel: other piece
3 C 15.2 20.0 1 × 1 × 1 from the same tumors
4 D 9.8 22.7 1.5 × 1.5 × 1.5
5 E 13.0 22.1 1 × 1.8 × 1.8
5 F 24.7
PBS in
D2O
1.2 × 1.2 × 1.2 after MRM
6 G 13.9 1 × 1 × 1
before MRM
4 H 11.1 1.5 × 1.5 × 1.5
In HRMAS experiments samples were spun at 4000 Hz.
The shimming was optimized checking the quality of the
signals and the resolution of the alanine doublet, usually
present in this kind of samples. HRMAS proton CPMG
spectra (Carr-Purcell-Meilboom-Gill) was performed with a
2D CPMG sequence with presaturation in the water signal.
2D CPMG spectra were acquired with a spectral width of
12 ppm/6000 Hz and the number of points in F2 was 16k.
The delay was fixed to 2 ms and the scan with 4 loops
gave and eﬀective TE of 16 ms. This was the nearest TE for
comparison with MRM PRESS single-voxel TE 12 ms.
3. Results and Discussion
MRM images of the samples without previous HRMAS
rotation (A–F) showed the tissue suspended in the solution
and without any relevant deformation of the piece. Examples
of these images (samples D and E) are shown in Figure 1.
On the contrary, MRM images in samples G and H clearly
showed the disposition of the tissue close to the rotor wall,
due to the eﬀect of high spinning speed on the previous
HRMAS study (see MRM axial images in Figure 1). In the
samples G and H, in which a previous HRMAS study was
acquired, the solution part that remained in the central axis
of the rotor (PBS in D2O) contained a considerable amount
of metabolites. This fact is clearly seen in the MRM single-
voxel spectrum of sample G (Figure 2(g), middle spectrum);
the main resonances were assigned to lactate, alanine, lipids,
creatine, choline, and phosphocholine, glycine and mannitol
(peaks are assigned in Figure 2(g), top spectrum) [9]. The
single-voxel spectrum in the tissue of sample G (Figure 2(g),
bottom spectrum) showed lower resolution than in solution
(Figure 2(g) middle spectrum), but still could be observed
lipids, creatine, choline, and mannitol resonances. In this
later single voxel, the tissue location close to the rotor wall
seriously precluded an adequate field homogeneity.
The HRMAS study of the separated solution part from
sample G (after the HRMAS and MRM study) confirmed the
metabolical content of the solution using the same technique
(Figure 3(d)). The resulting metabolic profile of the solution
was similar to the previous HRMAS CPMG spectrum in
the sample and to the MRM single-voxel spectrum in the
solution. The observation of this solution with a magnifying
glass (50x) assessed the absence of any tissue or cell in this
solution.
The samples either with pure D2O (A–C) or PBS in
D2O (D–F), but without previous rotation, also showed
transference of metabolites from the tissue to the medium
(Figure 2, middle spectra). A similar leakage of metabolites
had been reported in previously frozen samples [16]. The
metabolites appeared in the buﬀer solution (PBS in D2O)
immediately after thawing, and the amount of a given
metabolite observed in the medium varied from one biopsy
to another and was not proportional to the amount originally
present in the tissue [16]. Figure 2 gathers the MRM single-
voxel spectra from the tissue and the solution for all the
samples in this study. In all the cases the single-voxel spectra
in the solution showed the presence of metabolites.
There were substantial diﬀerences between the MRM
single-voxel spectra in solution and tissue parts. The most
striking diﬀerences were observed on the lipids, which almost
preponderantly appeared in the tissue single-voxel spectra (it
is very evident in samples A and C, see Figures 2(a) and 2(c),
bottom and middle spectra). In fact, the lipids are commonly
observed on GBM in vivo and ex vivo spectra and are
usually related to their aggressiveness. Moreover, quantitative
diﬀerences could be observed between the solution and the
tissue parts in other metabolites: in sample B the choline
derivatives proportion in the tissue and the solution was
diﬀerent, and in sample E the alanine was undetectable in
the tissue but it was present in the solution part.
Noteworthy, in the samples here studied the global
metabolic profiles observed either by MRM or by HRMAS
showed some significant diﬀerences, which is in agreement
with the heterogeneous nature of GBM tumor (areas of
actively growing tumor, necrosis, border infiltration, . . .)
[17]. The metabolite transfer from the tissue to the solution
was also diﬀerent, which agrees with previously published
studies on tissues [16], despite being preserved and studied
by the same procedures. An example of these diﬀerences can
be observed in the samples C and D (Figures 2(c) and 2(d)).
According to this, the percentage of the contribution of the
solution and tissue spectra to the whole HRMAS spectrum
might not be the same for each sample. In the sample C
the lipid content is high (as seen in HRMAS and MRM
tissue spectra) and a large part of these molecules remains
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Figure 1: The upper part shows the scheme of a rotor containing the sample and the solution and the axial MRM images of four samples.
The scheme of the HRMAS rotor shows the diﬀerent parts with the sample and the solution in the inner cavity. The position of the axial
plane is drawn with a magenta line and the axial view of the rotor on the right (upper part) shows the axial section, which is perpendicular
to the longitudinal axis of the rotor. Below, the set of MRM images shows 10 RARE axial slices and the central sagital and coronal planes for
each of the samples showing the shape of tissue pieces inside the rotor for samples D, E, G, and H. The position of the 10 axial images is
detailed by the 10 magenta horizontal lines in the sagital and coronal planes in each sample. Axial images are zoomed to achieve the optimal
view of the sample. In these MRM RARE images the solution, the rotor, and the air outside the rotor are darker than the tissue.
in the tissue whereas a small amount of low molecular
weight metabolites are transferred to the liquid environment
(Figure 2(c)). In this case, the main contribution to the
final global spectrum will came from the tissue. On the
contrary, sample D shows a low amount of lipids and hence,
an important part of low molecular weight metabolites is
observed in the solution, and the linear combination of
solution and tissue spectra will be diﬀerent to the one for the
sample C.
In the case of sample H, that underwent HRMAS previ-
ous to the MRM study, the eﬀect of metabolite transference
is such that even some lipids signals appear clearly in the
MRM spectrum in the solution part (Figure 2(h), bottom
spectrum). As it has been demonstrated in previous studies
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Figure 2: HRMAS CPMG (top) and MRM spectroscopy PRESS single-voxel spectra from solution (middle) and tissue (bottom) in each of
the samples (A–H). MRM single-voxel location in tissue (red box) and solution (yellow box) is illustrated in the MRM images. Samples G
and H were the only samples which underwent HRMAS experiments before MRM. Sample F underwent HRMAS study after MRM. The
samples A–E underwent parallel study by HRMAS in other piece from the same biopsies. The resonances assigned in the CPMG HRMAS
spectrum of sample G are: mannitol (Man), glycine (Gly), choline and phosphocholine (Cho), creatine (Cr), alanine (Ala), lactate (Lac),
and lipids (Lip). For each sample, the MRM images shown are those that better illustrate the tissue shape and position inside the rotor.
The MRM images shown for samples A and G belong to RARE sequences and the MRM images for samples B–F and H belong to MDEFT
images. Moreover, the contrast in these MRM image was balanced to enhance the diﬀerences between the tissue and the solution part.
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Figure 3: Three orthogonal planes allowed the location of single-voxel in the tissue part (red box) and in the solution (yellow box) for
sample G. (a) MRM spectroscopy single-voxel spectra in liquid part, (b) MRM spectroscopy single-voxel spectra in tissue part, (c) the linear
combination of spectra (a) and (b), (d) shows the HRMAS CPMG only on the solution collected after the MRM study, and (e) shows the
HRMAS CPMG on the whole sample before the MRM study.
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[14], the freezing-thawing and the ischemia processes are
not the only ones that can promote changes in the spectra
but also the high spinning speed of HRMAS study even at
low temperatures. In this type of samples, as G and H, the
expected eﬀect is still higher since the biopsies underwent
both freezing-thawing and HRMAS eﬀects, as usually in
the metabolomic studies involving HRMAS of biological
tissues.
It is also remarkable the diﬀerent peak width of these
resonances coming from the tissue and the solution parts
(Figure 2(e), bottom and middle, resp.), with two diﬀerent
contributions to the HRMAS overall spectrum. The eﬀect
is a broadening in the base of the peaks (Figure 2(e), top
spectrum) that can be a drawback when automated analyses
strategies are used. Like the linewidths, also the chemical
shifts of metabolites within the tissue and outside in the
solution may be diﬀerent, and this may reduce the accuracy
of quantification [16].
4. Conclusion
In conclusion, the MRM approach here presented allowed
to visualize the great distortion of the brain tumor tis-
sue produced by the HRMAS spinning and to detect a
selective transference of metabolites from the tissue to the
medium, even in nonstressing osmotic conditions. Our
analysis implies that in some cases HRMAS spectra could
correspond mainly to a solution and not so to an “intact”
tissue. This eﬀect must be accounted for in the subsequent
quantification and interpretation of the results of HRMAS
spectra in tissues, since the transference from the tissue to
the solution is not equivalent for all the metabolites and
for all the samples, and can also be influenced by the way
in which the sample has been obtained and preserved. It
might be expected a diﬀerent contribution to the HRMAS
spectrum of those metabolites transferred to the solution and
those which preferentialy remain in the tissue (in fact, the
relaxation conditions are characteristically diﬀerent in the
tissue and in the solution, and therefore the shape of the
peaks can experiment considerable variations). The MRM
analysis provides a connection between the microscopic
image and the metabolic composition, yielding spatially
localized molecular information that can be relevant in the
correlation with other molecular imaging techniques and in
the understanding of their biochemical significance.
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